Katherine Sacksteder active positions
| Companies | Position | Start | End |
|---|---|---|---|
BeneVir Biopharm, Inc.
 BeneVir Biopharm, Inc. BiotechnologyHealth Technology BeneVir Biopharm, Inc. develops oncolytic immunotherapies software for advanced solid tumors. It offers oncolytic immunotherapy, that attacks and kill cancer cells. The company was founded by Katherine Sacksteder, Matthew Charles Mulvey and Ian Mohr in 2011 and is headquartered in Rockville, MD. | Chief Operating Officer | 2010-12-31 | - |
| Founder | 2010-12-31 | - |
Career history of Katherine Sacksteder
Former positions of Katherine Sacksteder
| Companies | Position | Start | End |
|---|---|---|---|
Sequella, Inc.
 Sequella, Inc. Pharmaceuticals: MajorHealth Technology Sequella, Inc. develops antibiotic drugs resistant to bacterial, fungal, and parasitic infections. It offers product for Mycobacterium tuberculosis, Helicobacter pylori, Clostridium difficile, Nontuberculous mycobacteria, Trypanosomes, and fungal infections. The company was founded by Carol A. Nacy and Leo Einck in 1997 and is headquartered in Rockville, MD. | Corporate Officer/Principal | - | - |
Statistics
International
| United States | 3 |
Operational
| Corporate Officer/Principal | 1 |
| Chief Operating Officer | 1 |
| Founder | 1 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Sequella, Inc.
Sequella, Inc. Pharmaceuticals: MajorHealth Technology Sequella, Inc. develops antibiotic drugs resistant to bacterial, fungal, and parasitic infections. It offers product for Mycobacterium tuberculosis, Helicobacter pylori, Clostridium difficile, Nontuberculous mycobacteria, Trypanosomes, and fungal infections. The company was founded by Carol A. Nacy and Leo Einck in 1997 and is headquartered in Rockville, MD. | Health Technology |
BeneVir Biopharm, Inc.
BeneVir Biopharm, Inc. BiotechnologyHealth Technology BeneVir Biopharm, Inc. develops oncolytic immunotherapies software for advanced solid tumors. It offers oncolytic immunotherapy, that attacks and kill cancer cells. The company was founded by Katherine Sacksteder, Matthew Charles Mulvey and Ian Mohr in 2011 and is headquartered in Rockville, MD. | Health Technology |
- Stock Market
- Insiders
- Katherine Sacksteder
- Experience
